Eli Lilly and Company

Eli Lilly and Company is a leading pharmaceutical firm with a global reputation for developing and marketing innovative medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, the company operates within the pharmaceuticals and biotechnology sector, addressing a wide spectrum of diseases through prescription drugs and biopharmaceutical products. Eli Lilly’s research and development efforts have produced treatments in areas such as oncology, endocrinology (notably diabetes care), immunology, neuroscience, and rare diseases, making it a key player in improving patient outcomes across multiple therapeutic segments. The company's large scale is reflected in its substantial market capitalization, its listing on major exchanges, and its presence in over 120 countries. Eli Lilly’s continued investment in clinical research and strategic collaborations underscores its pivotal role in driving advancements within the pharmaceutical industry, impacting both healthcare systems and patients worldwide.